SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired Kyverna Therapeutics, Inc. (Nasdaq: KYTX) (“Kyverna” or the “Company”) common stock pursuant and/or traceable to the Company’s registration statement issued in connection with its initial public offering (“IPO”) held on February 8, 2024. The Kyverna lawsuit charges the Company, certain of its current and former senior executives and directors, and the u ...